Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Sep 21, 2009; 15(35): 4415-4422
Published online Sep 21, 2009. doi: 10.3748/wjg.15.4415
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Chemotherapy treatment patterns across all settings in patients with GEC (n = 1013).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Distribution of chemotherapy by treatment setting.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Adjusted complication hazard ratio: 5-FU vs capecitabine regimens. A: 5-FU monotherapy compared with capecitabine monotherapy; B: 5-FU combination compared with capecitabine combination; C: Any 5-FU regimen compared with any capecitabine regimen. Complications were determined per 1000 person-months.